Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly

Topline Pharmaceutical heavyweight Novo Nordisk on Tuesday announced it is cutting prices for several insulin drugs in the U.S., following a similar move from drugmaker Eli Lilly as healthcare compani...

Eli Lilly and Novo Stock Sold Off. Don’t Blame Their Diet Drugs.

Stock in Eli Lilly and Novo Nordisk outperformed last year, largely because of remarkable demand for new drugs that drive weight loss in patients afflicted with diabetes and obesity. Both stocks were ...

Novo Nordisk 4Q Sales DKK48.09B

By Dominic Chopping Danish pharmaceutical company Novo Nordisk AS on Wednesday raised its dividend and launched a new 28 billion Danish kroner ($4.09 billion) share buyback after fourth-quarter earnin...

NVO Stock Jumps After Novo Nordisk Expands Diabetes Lead Over Pfizer, Eli Lilly

The Food and Drug Administration expanded the label for Novo Nordisk‘s (NVO) oral diabetes medicine, leading NVO stock to jump Friday. X Now, patients with type 2 diabetes can take Rybelsus with...

Despite Market Turmoil, Technology Gains Persist Across Industries

Every year, TrueBridge analyzes the Next Billion-Dollar Startups to spotlight the trends shaping the next wave of industry disruptors. Last year, we discussed how the convenience and innovation of dig...